vs

Side-by-side financial comparison of Empire State Realty Trust, Inc. (ESRT) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $199.2M, roughly 1.0× Empire State Realty Trust, Inc.). Empire State Realty Trust, Inc. runs the higher net margin — 16.1% vs 2.7%, a 13.5% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 0.8%). Empire State Realty Trust, Inc. produced more free cash flow last quarter ($50.6M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 4.9%).

Empire State Realty Trust is a leading real estate investment trust that owns, manages, and operates a portfolio of premium commercial, residential, and retail properties primarily in the New York City metropolitan area, including the iconic Empire State Building. It serves corporate tenants, retail partners, and residential occupants, focusing on sustainable property operations and long-term asset value growth.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

ESRT vs IRTC — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.0× larger
IRTC
$208.9M
$199.2M
ESRT
Growing faster (revenue YoY)
IRTC
IRTC
+26.3% gap
IRTC
27.1%
0.8%
ESRT
Higher net margin
ESRT
ESRT
13.5% more per $
ESRT
16.1%
2.7%
IRTC
More free cash flow
ESRT
ESRT
$36.1M more FCF
ESRT
$50.6M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
4.9%
ESRT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESRT
ESRT
IRTC
IRTC
Revenue
$199.2M
$208.9M
Net Profit
$32.2M
$5.6M
Gross Margin
70.9%
Operating Margin
17.8%
1.1%
Net Margin
16.1%
2.7%
Revenue YoY
0.8%
27.1%
Net Profit YoY
71.2%
518.5%
EPS (diluted)
$0.11
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESRT
ESRT
IRTC
IRTC
Q4 25
$199.2M
$208.9M
Q3 25
$197.7M
$192.9M
Q2 25
$191.3M
$186.7M
Q1 25
$180.1M
$158.7M
Q4 24
$197.6M
$164.3M
Q3 24
$199.6M
$147.5M
Q2 24
$189.5M
$148.0M
Q1 24
$181.2M
$131.9M
Net Profit
ESRT
ESRT
IRTC
IRTC
Q4 25
$32.2M
$5.6M
Q3 25
$13.6M
$-5.2M
Q2 25
$11.4M
$-14.2M
Q1 25
$15.8M
$-30.7M
Q4 24
$18.8M
$-1.3M
Q3 24
$22.8M
$-46.2M
Q2 24
$28.6M
$-20.1M
Q1 24
$10.2M
$-45.7M
Gross Margin
ESRT
ESRT
IRTC
IRTC
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Q1 24
66.3%
Operating Margin
ESRT
ESRT
IRTC
IRTC
Q4 25
17.8%
1.1%
Q3 25
19.9%
-4.4%
Q2 25
18.4%
-10.0%
Q1 25
14.3%
-20.5%
Q4 24
21.7%
-2.5%
Q3 24
22.7%
-34.1%
Q2 24
20.8%
-15.5%
Q1 24
17.1%
-28.9%
Net Margin
ESRT
ESRT
IRTC
IRTC
Q4 25
16.1%
2.7%
Q3 25
6.9%
-2.7%
Q2 25
6.0%
-7.6%
Q1 25
8.8%
-19.3%
Q4 24
9.5%
-0.8%
Q3 24
11.4%
-31.3%
Q2 24
15.1%
-13.6%
Q1 24
5.6%
-34.6%
EPS (diluted)
ESRT
ESRT
IRTC
IRTC
Q4 25
$0.11
$0.18
Q3 25
$0.05
$-0.16
Q2 25
$0.04
$-0.44
Q1 25
$0.05
$-0.97
Q4 24
$0.07
$-0.03
Q3 24
$0.08
$-1.48
Q2 24
$0.10
$-0.65
Q1 24
$0.03
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESRT
ESRT
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$132.7M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$152.7M
Total Assets
$4.5B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESRT
ESRT
IRTC
IRTC
Q4 25
$132.7M
$583.8M
Q3 25
$154.1M
$565.2M
Q2 25
$94.6M
$545.5M
Q1 25
$187.8M
$520.6M
Q4 24
$385.5M
$535.6M
Q3 24
$421.9M
$522.0M
Q2 24
$535.5M
$561.5M
Q1 24
$333.6M
$569.1M
Stockholders' Equity
ESRT
ESRT
IRTC
IRTC
Q4 25
$1.1B
$152.7M
Q3 25
$1.0B
$121.9M
Q2 25
$1.0B
$103.7M
Q1 25
$1.0B
$86.7M
Q4 24
$1.0B
$90.9M
Q3 24
$1.0B
$71.8M
Q2 24
$1.0B
$99.2M
Q1 24
$996.1M
$90.3M
Total Assets
ESRT
ESRT
IRTC
IRTC
Q4 25
$4.5B
$1.0B
Q3 25
$4.1B
$995.2M
Q2 25
$4.1B
$964.0M
Q1 25
$4.1B
$926.1M
Q4 24
$4.5B
$931.4M
Q3 24
$4.4B
$909.7M
Q2 24
$4.4B
$919.2M
Q1 24
$4.2B
$909.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESRT
ESRT
IRTC
IRTC
Operating Cash FlowLast quarter
$249.1M
$26.2M
Free Cash FlowOCF − Capex
$50.6M
$14.5M
FCF MarginFCF / Revenue
25.4%
6.9%
Capex IntensityCapex / Revenue
99.6%
5.6%
Cash ConversionOCF / Net Profit
7.74×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$109.3M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESRT
ESRT
IRTC
IRTC
Q4 25
$249.1M
$26.2M
Q3 25
$105.3M
$34.9M
Q2 25
$26.7M
$27.7M
Q1 25
$83.1M
$-7.9M
Q4 24
$260.9M
$19.2M
Q3 24
$102.8M
$24.3M
Q2 24
$37.1M
$11.8M
Q1 24
$70.9M
$-52.0M
Free Cash Flow
ESRT
ESRT
IRTC
IRTC
Q4 25
$50.6M
$14.5M
Q3 25
$72.8M
$20.1M
Q2 25
$-55.1M
$17.3M
Q1 25
$41.1M
$-17.3M
Q4 24
$88.0M
$12.4M
Q3 24
$-65.1M
$15.5M
Q2 24
$19.5M
$3.4M
Q1 24
$23.2M
$-61.8M
FCF Margin
ESRT
ESRT
IRTC
IRTC
Q4 25
25.4%
6.9%
Q3 25
36.8%
10.4%
Q2 25
-28.8%
9.3%
Q1 25
22.8%
-10.9%
Q4 24
44.5%
7.5%
Q3 24
-32.6%
10.5%
Q2 24
10.3%
2.3%
Q1 24
12.8%
-46.8%
Capex Intensity
ESRT
ESRT
IRTC
IRTC
Q4 25
99.6%
5.6%
Q3 25
16.5%
7.7%
Q2 25
42.8%
5.6%
Q1 25
23.4%
5.9%
Q4 24
87.5%
4.2%
Q3 24
84.1%
6.0%
Q2 24
9.3%
5.7%
Q1 24
26.3%
7.4%
Cash Conversion
ESRT
ESRT
IRTC
IRTC
Q4 25
7.74×
4.70×
Q3 25
7.72×
Q2 25
2.35×
Q1 25
5.27×
Q4 24
13.88×
Q3 24
4.51×
Q2 24
1.30×
Q1 24
6.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESRT
ESRT

Real Estate Segment$163.8M82%
Observatory Segment$35.2M18%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons